Submitted by Anonymous (not verified) on 18 December 2024 - 11:15
Human medicines European public assessment report (EPAR): Lynparza, olaparib, Date of authorisation: 16/12/2014, Revision: 27, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Lynparza, olaparib, Date of authorisation: 16/12/2014, Revision: 27, Status: Authorised